Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

CGRP Inhibitors and Oxidative Stress Biomarkers in Resistant Migraine: A Real-Life Study with Erenumab, Fremanezumab, and Galcanezumab
Ciro De Luca, Filippo Baldacci, Sonia Mazzucchi, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 19, pp. 4586-4586
Open Access | Times Cited: 18

Showing 18 citing articles:

Pathophysiology and Therapy of Associated Features of Migraine
María Dolores Villar‐Martínez, Peter J. Goadsby
Cells (2022) Vol. 11, Iss. 17, pp. 2767-2767
Open Access | Times Cited: 46
Monoclonal Antibodies against Calcitonin Gene-Related Peptide for Migraine Prophylaxis: A Systematic Review of Real-World Data
Antun R. Pavelić, Christian Wöber, Franz Riederer, et al.
Cells (2022) Vol. 12, Iss. 1, pp. 143-143
Open Access | Times Cited: 38
Oxidative Stress and Migraine
Félix Javier Jiménez‐Jiménez, Hortensia Alonso‐Navarro, Elena García‐Martín, et al.
Molecular Neurobiology (2024) Vol. 61, Iss. 10, pp. 8344-8360
Closed Access | Times Cited: 10
Energy metabolism disturbance in migraine: From a mitochondrial point of view
Yi‐Cheng Wang, Yongli Wang, Guang-Xin Yue, et al.
Frontiers in Physiology (2023) Vol. 14
Open Access | Times Cited: 18
Calcitonin gene-related peptide-induced central sensitization: A hypothesis for long COVID symptoms
E Lee, C. S. Sidney Tsang, Marco Pérez, et al.
Medical Hypotheses (2025) Vol. 195, pp. 111570-111570
Closed Access
Beyond Pain Relief: Unveiling the Multifaceted Impact of Anti-CGRP/R mAbs on Comorbid Symptoms in Resistant Migraine Patients
Alessandra Della Vecchia, Ciro De Luca, Lucrezia Becattini, et al.
Biomedicines (2024) Vol. 12, Iss. 3, pp. 677-677
Open Access | Times Cited: 3
Monoclonal Antibodies Against Calcitonin Gene-related Peptide for Migraine Prophylaxis: A Systematic Review of Real-world Data
Antun R. Pavelić, Christian Wöber, Franz Riederer, et al.
(2022)
Open Access | Times Cited: 9
Therapies targeting CGRP signaling for medication overuse headache
Ioannis‐Alexios Koumprentziotis, Dimos D. Mitsikostas
Current Opinion in Neurology (2022) Vol. 35, Iss. 3, pp. 353-359
Closed Access | Times Cited: 8
Early Improvement of Affective, Fatigue and Allodynic Symptoms in a Cohort of Resistant Migraineurs Treated with Anti-CGRP/R Antibodies
Alessandra Della Vecchia, Ciro De Luca, Lucrezia Becattini, et al.
(2024)
Open Access | Times Cited: 1
Erenumab Impact on Sleep Assessed With Questionnaires and Home-Polysomnography in Patients With Migraine: The ERESON Study
Gaia Pellitteri, Sara Pez, Annacarmen Nilo, et al.
Frontiers in Neurology (2022) Vol. 13
Open Access | Times Cited: 6
Real-World Effectiveness of Calcitonin Gene–Related Peptide-Binding Monoclonal Antibodies for Migraine Prevention: A Systematic Review
Andrea Zovi, Roberto Langella, Anna Chiara Aloisi, et al.
The Canadian Journal of Hospital Pharmacy (2023) Vol. 77, Iss. 1
Open Access | Times Cited: 3
The Spatiotemporal Coupling: Regional Energy Failure and Aberrant Proteins in Neurodegenerative Diseases
Assunta Virtuoso, Anna Maria Colangelo, Nicola Maggio, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 21, pp. 11304-11304
Open Access | Times Cited: 7
Effectiveness of galcanezumab on sleep quality, migraine outcome, and multidimensional patient-reported outcome measures: a real-world experience in Turkish patients with episodic and chronic migraine
Elif Ilgaz Aydınlar, Tuba Erdoğan Soyukibar, Pınar Yalinay Dikmen
Frontiers in Neurology (2024) Vol. 15
Open Access
Dissecting Migraine: The Future of Anatomical, Functional, and Liquid Biomarkers
Ciro De Luca, Filippo Baldacci
Journal of Clinical Medicine (2022) Vol. 11, Iss. 19, pp. 5538-5538
Open Access | Times Cited: 2
LEVELS OF MALONDIALDEHYDE AND CALCITONIN GENE-RELATED PEPTIDE IN PULP INFLAMMATION DUE TO LPS INDUCTION DURATION
Arlina Nurhapsari, Andina Rizkia Putri Kusuma
Deleted Journal (2022) Vol. 9, Iss. 1, pp. 148-148
Open Access | Times Cited: 1
Preventive treatment modifies endothelial function and oxidative stress status in patients with migraine: an observational study
C. González Mingot, Sonia Santos Lasaosa, Laura Colàs‐Campàs, et al.
Research Square (Research Square) (2023)
Open Access
Prophylactic treatment can modify vascular risk biomarkers in high-frequency episodic and chronic migraine patients: a pilot study
C. González Mingot, Sonia Santos Lasaosa, Laura Colàs‐Campàs, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access
Anti-CGRP mAbs for the Preventive Treatment of Migraine: An Overview Review and a Cost Saving Analysis in the Global Scenario
Andrea Zovi, Ruggero Lasala, Francesco Ferrara, et al.
Hospital Pharmacy (2023) Vol. 59, Iss. 2, pp. 165-172
Open Access
Page 1

Scroll to top